Rezultati - Carl D. Regillo

Refine Results
  1. 1
    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration

    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration od Carl D. Regillo, Brandon Busbee, Allen C. Ho, Beiying Ding, Zdenka Hašková

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration

    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration od David S. Boyer, K. Bailey Freund, Carl D. Regillo, Marc H. Levy, Sumit Garg

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials od Charles C. Wykoff, Michael J. Elman, Carl D. Regillo, Beiying Ding, Na Lu, Ivaylo Stoilov

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System od John S. Wittenborn, Traci E. Clemons, Carl D. Regillo, Nadim Rayess, Danielle Kruger, David B. Rein

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration od Allen C. Ho, Brandon Busbee, Carl D. Regillo, Mark R. Wieland, Sherri A. Van Everen, Zhengrong Li, Roman G. Rubio, Phillip Lai

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic

    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic od Luv Patel, Travis Peck, Matthew R. Starr, Michael J. Ammar, Khan Ma, Yoshihiro Yonekawa, Michael A. Klufas, Carl D. Regillo, Allen C. Ho, David Xu

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION

    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION od Anton Orlin, Dexter Hadley, Woohyok Chang, Allen C. Ho, Gary C. Brown, Richard Kaiser, Carl D. Regillo, Ashlee N. Godshalk, Audun Lier, Brian Kaderli, Dwight Stambolian

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor

    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor od Anthony Obeid, Daniel Su, Samir Patel, Joshua H. Uhr, Durga S. Borkar, Xinxiao Gao, Mitchell S. Fineman, Carl D. Regillo, Joseph I. Maguire, Sunir J. Garg, Jason Hsu

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study od Arshad M. Khanani, David S. Boyer, Charles C. Wykoff, Carl D. Regillo, Brandon Busbee, Dante J. Pieramici, Carl J. Danzig, Brian C. Joondeph, James C. Major, Adam Turpcu, Szilárd Kiss

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Juxtapapillary capillary hemangiomas

    Juxtapapillary capillary hemangiomas od Cathleen M. McCabe, Harry W. Flynn, Carol L Shields, Jerry A. Shields, Carl D Regillo, H. Richard McDonald, María H. Berrocal, J. Donald M. Gass, William F. Mieler

    Izdano 2000
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials od Gui‐shuang Ying, Benjamin J. Kim, Maureen G. Maguire, Jiayan Huang, Ebenezer Daniel, Glenn J. Jaffe, Juan E. Grunwald, Kevin J. Blinder, Christina J. Flaxel, Firas M. Rahhal, Carl D. Regillo, Daniel Martín

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES

    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES od K. Bailey Freund, Jean‐François Korobelnik, Robert G. Devenyi, Carsten Framme, John Galic, Edward N. Herbert, Hans Hoerauf, Paolo Lanzetta, Stephan Michels, Paul Mitchell, Jordi Monés, Carl D. Regillo, Ramin Tadayoni, James Talks, Sebastián Wolf

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema od Charles C. Wykoff, Justus G. Garweg, Carl D. Regillo, Eric H. Souied, Sebastián Wolf, Dilsher S. Dhoot, Hansjuergen Agostini, Andrew Chang, Augustinus Laude, J Wachtlin, Lidija Kovacic, Lixin Wang, Ying Wang, Emmanuel Bouillaud, David M. Brown

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration od Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh, Carl D. Regillo, Anthony P. Adamis, Vladimir Bantseev, Ya‐Wen Chiang, Jason S. Ehrlich, Signe Erickson, William D. Hanley, Joshua Horvath, Katie F. Maass, Natasha Singh, Fan Tang, Giulio Barteselli

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections

    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections od Samir Patel, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rebecca R. Soares, John W. Hinkle, Jason Hsu, Sunir J. Garg, Carl D. Regillo, Allen C. Ho, Michael N. Cohen, Khan Ma, Yoshihiro Yonekawa, Allen Chiang, Omesh P. Gupta, Ajay E. Kuriyan

    Izdano 2020
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration

    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration od Brian L. Yaspan, David F. Williams, Frank G. Holz, Carl D. Regillo, Zhengrong Li, Amy Dressen, Menno van Lookeren Campagne, Kha Le, Robert Graham, Tatiana Beres, Tushar Bhangale, Lee Honigberg, Ashley Smith, Erin C. Henry, Carole Ho, Erich C. Strauss

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Primary Retinal Detachment Outcomes Study Report Number 2

    Primary Retinal Detachment Outcomes Study Report Number 2 od Edwin H. Ryan, Claire Ryan, Nora J. Forbes, Yoshihiro Yonekawa, Sushant Wagley, Robert A. Mittra, D. Wilkin Parke, Daniel P. Joseph, Geoffrey G. Emerson, Gaurav K. Shah, Kevin J. Blinder, Antonio Capone, George A. Williams, Dean Eliott, Omesh P. Gupta, Jason Hsu, Carl D. Regillo

    Izdano 2020
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Artificial Intelligence Detection of Diabetic Retinopathy

    Artificial Intelligence Detection of Diabetic Retinopathy od Jennifer I. Lim, Carl D. Regillo, Srinivas R. Sadda, Eli Ipp, Malavika Bhaskaranand, Chaithanya Ramachandra, Kaushal Solanki, Harvey Dubiner, Grace A. Levy-Clarke, Richard D. Pesavento, Mark D. Sherman, Steven Silverstein, Brian Kim, Gerald B. Walman, Barbara A. Blodi, Amitha Domalpally, Susan Reed, James Reimers, Kris Lang, Holy Cohn, Ruth Shaw, Sheila Watson, Andrew Ewen, Nancy Barrett, Maria Swift, Jeffrey Gornbein

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial od Lyndon da Cruz, Jessy D. Dorn, Mark S. Humayun, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Allen C. Ho, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Robert J. Greenberg

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind

    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind od Allen C. Ho, Mark S. Humayun, Jessy D. Dorn, Lyndon da Cruz, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Duane R. Geruschat, Robert J. Greenberg

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: